2 terminated, 1 completed, 1 suspended. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Suspended 1 |
Follow Acute Promyelocytic Leukemia: new trials by email Literature Review of Acute Promyelocytic Leukemia trials Research Report on Acute Promyelocytic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia SY-2101, Arsenic Trioxide - Acute Promyelocytic Leukemia | Phase 1 | Suspended | Syros Pharmaceuticals | 16 | 2021-09-17 | 2024-01-23 |
| A Safety Study of SGN-CD33A in AML Patients HMA, SGN-CD33A - Acute Myelogenous Leukemia, Acute Myeloid Leukemia | Phase 1 | Completed | Seagen Inc. | 195 | 2013-07-01 | 2018-01-05 |
| Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia Tamibarotene, Arsenic trioxide - Acute Promyelocytic Leukemia | Phase 1 | Terminated | Northwestern University | 4 | 2009-10-01 | 2013-10-30 |
| Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias Clofarabine, Cyclophosphamide - Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 35 | 2007-09-01 | 2018-02-15 |
Leukemia, Promyelocytic, Acute (4) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Myelomonocytic, Juvenile (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1) · Recurrence (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Leukemia (4) · Leukemia, Myeloid (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Leukemia, Myeloid, Acute (2) · Bone Marrow Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1)
Arsenic Trioxide (2) · Clofarabine (1) · Cyclophosphamide (1) · cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) (1) · tamibarotene (1) · vadastuximab talirine (1)
Northwestern University (1) · Seagen Inc. (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Syros Pharmaceuticals (1)
United States (4) · Canada (1)
Phoenix Ho, MD (1)